Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $365.0000 (-6.41%) ($342.5000 - $395.0000) on Thu. Jul. 21, 2011. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.06% (three month average) | RSI | 45 | Latest Price | $365.0000(-6.41%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -1.3% a day on average for past five trading days. | Weekly Trend | CAPR declines -3.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(4%) EWP(3%) IWM(3%) XOP(3%) EWI(2%) | Factors Impacting CAPR price | CAPR will decline at least -3.03% in a week (0% probabilities). REMX(-1%) IGOV(-1%) EWY(-1%) XLU(0%) XLP(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.03% (StdDev 6.06%) | Hourly BBV | 0 () | Intraday Trend | 6.6% | | | |
|
Resistance Level | $380.34 | 5 Day Moving Average | $373(-2.14%) | 10 Day Moving Average | $380.71(-4.13%) | 20 Day Moving Average | $380.34(-4.03%) | To recent high | -12% | To recent low | 30.4% | Market Cap | $7.19b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |